Although JAK2 is phosphorylated in cytokine-independent BCR-ABL-positive CML cells, aberrant JAK/STAT signaling has been implicated in various tumors [14]. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.